Jagsonpal Pharmaceuticals (India) Price History
JAGSNPHARM | 639.65 23.25 3.77% |
Below is the normalized historical share price chart for Jagsonpal Pharmaceuticals Limited extending back to July 01, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Jagsonpal Pharmaceuticals stands at 639.65, as last reported on the 27th of December, with the highest price reaching 649.00 and the lowest price hitting 607.15 during the day.
If you're considering investing in Jagsonpal Stock, it is important to understand the factors that can impact its price. Jagsonpal Pharmaceuticals appears to be very steady, given 3 months investment horizon. Jagsonpal Pharmaceuticals holds Efficiency (Sharpe) Ratio of 0.18, which attests that the entity had a 0.18% return per unit of risk over the last 3 months. By evaluating Jagsonpal Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk. Please utilize Jagsonpal Pharmaceuticals' Downside Deviation of 3.08, risk adjusted performance of 0.1411, and Market Risk Adjusted Performance of 0.6922 to validate if our risk estimates are consistent with your expectations.
As of now, Jagsonpal Pharmaceuticals' Common Stock Shares Outstanding is increasing as compared to previous years. The Jagsonpal Pharmaceuticals' current Common Stock is estimated to increase to about 144.2 M, while Total Stockholder Equity is projected to decrease to under 1.2 B. . Jagsonpal Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 418.3538 | 50 Day MA 601.671 | Beta 1.055 |
Jagsonpal |
Sharpe Ratio = 0.1836
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | JAGSNPHARM | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
4.32 actual daily | 38 62% of assets are more volatile |
Expected Return
0.79 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
0.18 actual daily | 14 86% of assets perform better |
Based on monthly moving average Jagsonpal Pharmaceuticals is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jagsonpal Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 8.5744 | Book Value 74.422 | Enterprise Value 16.3 B | Enterprise Value Ebitda 43.5588 | Price Sales 7.2386 |
Jagsonpal Pharmaceuticals Stock Price History Chart
There are several ways to analyze Jagsonpal Stock price data. The simplest method is using a basic Jagsonpal candlestick price chart, which shows Jagsonpal Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 29, 2024 | 761.2 |
Lowest Price | October 7, 2024 | 404.3 |
Jagsonpal Pharmaceuticals December 27, 2024 Stock Price Synopsis
Various analyses of Jagsonpal Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Jagsonpal Stock. It can be used to describe the percentage change in the price of Jagsonpal Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Jagsonpal Stock.Jagsonpal Pharmaceuticals Price Rate Of Daily Change | 1.04 | |
Jagsonpal Pharmaceuticals Price Action Indicator | 23.20 | |
Jagsonpal Pharmaceuticals Accumulation Distribution | 5,941 | |
Jagsonpal Pharmaceuticals Price Daily Balance Of Power | 0.56 | |
Jagsonpal Pharmaceuticals Market Facilitation Index | 0.0005 |
Jagsonpal Pharmaceuticals December 27, 2024 Stock Price Analysis
Jagsonpal Stock Price History Data
The price series of Jagsonpal Pharmaceuticals for the period between Sat, Sep 28, 2024 and Fri, Dec 27, 2024 has a statistical range of 356.9 with a coefficient of variation of 19.19. Under current investment horizon, the daily prices are spread out with arithmetic mean of 561.04. The median price for the last 90 days is 569.95. The company completed 2.5:1 stock split on 8th of January 2025. Jagsonpal Pharmaceuticals completed dividends distribution on 2024-09-06.Open | High | Low | Close | Volume | ||
12/27/2024 | 614.00 | 649.00 | 607.15 | 639.65 | 92,132 | |
12/26/2024 | 635.75 | 637.90 | 614.00 | 616.40 | 52,349 | |
12/24/2024 | 649.00 | 669.95 | 630.60 | 636.65 | 56,188 | |
12/23/2024 | 664.10 | 664.10 | 638.45 | 646.45 | 62,352 | |
12/20/2024 | 695.10 | 698.40 | 654.00 | 657.60 | 68,344 | |
12/19/2024 | 685.00 | 697.00 | 666.10 | 688.30 | 62,269 | |
12/18/2024 | 720.50 | 729.95 | 683.10 | 688.05 | 83,811 | |
12/17/2024 | 707.00 | 728.00 | 705.00 | 713.50 | 187,921 | |
12/16/2024 | 673.85 | 705.00 | 670.35 | 700.85 | 174,557 | |
12/13/2024 | 660.00 | 679.00 | 647.45 | 672.45 | 95,093 | |
12/12/2024 | 681.95 | 681.95 | 659.90 | 662.90 | 40,757 | |
12/11/2024 | 664.70 | 698.95 | 660.65 | 678.35 | 171,077 | |
12/10/2024 | 689.00 | 705.00 | 651.00 | 663.15 | 148,516 | |
12/09/2024 | 678.70 | 692.45 | 671.85 | 682.30 | 69,804 | |
12/06/2024 | 702.05 | 710.95 | 679.95 | 685.90 | 84,852 | |
12/05/2024 | 711.30 | 732.35 | 696.00 | 699.85 | 139,836 | |
12/04/2024 | 719.00 | 725.00 | 701.15 | 708.55 | 118,667 | |
12/03/2024 | 740.00 | 767.00 | 698.65 | 714.10 | 445,523 | |
12/02/2024 | 762.00 | 814.25 | 731.00 | 734.70 | 443,233 | |
11/29/2024 | 697.00 | 820.10 | 687.05 | 761.20 | 1,040,787 | |
11/28/2024 | 671.10 | 694.95 | 668.45 | 683.45 | 78,996 | |
11/27/2024 | 696.00 | 703.70 | 668.25 | 673.00 | 109,427 | |
11/26/2024 | 684.00 | 726.65 | 669.15 | 696.20 | 558,767 | |
11/25/2024 | 648.00 | 686.00 | 643.95 | 671.00 | 397,248 | |
11/22/2024 | 594.45 | 655.00 | 582.75 | 637.70 | 567,270 | |
11/21/2024 | 576.00 | 605.95 | 568.60 | 592.60 | 98,580 | |
11/20/2024 | 576.60 | 576.60 | 576.60 | 576.60 | 1.00 | |
11/19/2024 | 597.65 | 622.50 | 566.35 | 576.60 | 165,112 | |
11/18/2024 | 533.50 | 599.00 | 533.50 | 591.10 | 125,001 | |
11/14/2024 | 533.60 | 550.00 | 527.30 | 533.50 | 43,064 | |
11/13/2024 | 559.10 | 571.95 | 525.75 | 532.00 | 60,964 | |
11/12/2024 | 568.80 | 597.95 | 545.00 | 561.45 | 82,287 | |
11/11/2024 | 593.20 | 600.00 | 564.05 | 569.95 | 48,817 | |
11/08/2024 | 610.00 | 610.00 | 577.25 | 591.50 | 58,910 | |
11/07/2024 | 607.75 | 628.85 | 589.05 | 598.30 | 148,870 | |
11/06/2024 | 604.65 | 615.00 | 585.05 | 608.75 | 163,652 | |
11/05/2024 | 541.00 | 607.00 | 536.60 | 599.45 | 542,952 | |
11/04/2024 | 551.00 | 555.65 | 526.95 | 539.15 | 89,435 | |
11/01/2024 | 542.70 | 542.70 | 542.70 | 542.70 | 21,769 | |
10/31/2024 | 523.90 | 564.00 | 512.05 | 542.70 | 561,264 | |
10/30/2024 | 461.20 | 554.90 | 460.00 | 521.65 | 564,755 | |
10/29/2024 | 466.45 | 470.00 | 457.05 | 466.90 | 19,749 | |
10/28/2024 | 452.40 | 475.00 | 449.25 | 469.50 | 46,726 | |
10/25/2024 | 473.05 | 474.40 | 440.75 | 451.10 | 106,791 | |
10/24/2024 | 499.80 | 499.80 | 472.60 | 477.75 | 294,841 | |
10/23/2024 | 455.95 | 490.20 | 437.95 | 473.35 | 98,603 | |
10/22/2024 | 488.55 | 494.70 | 451.40 | 456.20 | 91,295 | |
10/21/2024 | 473.95 | 499.90 | 462.05 | 487.30 | 324,228 | |
10/18/2024 | 469.05 | 474.95 | 454.00 | 464.25 | 48,093 | |
10/17/2024 | 479.40 | 480.15 | 462.15 | 473.45 | 174,862 | |
10/16/2024 | 454.20 | 457.40 | 446.00 | 449.40 | 20,340 | |
10/15/2024 | 458.00 | 464.95 | 441.00 | 454.20 | 44,871 | |
10/14/2024 | 469.40 | 484.40 | 455.00 | 457.25 | 68,558 | |
10/11/2024 | 465.00 | 474.80 | 458.10 | 469.40 | 47,410 | |
10/10/2024 | 453.70 | 474.00 | 445.05 | 466.10 | 125,119 | |
10/09/2024 | 415.95 | 495.60 | 415.05 | 451.85 | 404,899 | |
10/08/2024 | 410.00 | 416.00 | 400.55 | 413.00 | 49,984 | |
10/07/2024 | 437.65 | 442.95 | 396.55 | 404.30 | 74,601 | |
10/04/2024 | 439.80 | 450.00 | 424.30 | 436.55 | 61,570 | |
10/03/2024 | 414.00 | 442.95 | 410.15 | 434.65 | 58,264 | |
10/01/2024 | 416.00 | 433.80 | 415.00 | 430.20 | 48,261 |
About Jagsonpal Pharmaceuticals Stock history
Jagsonpal Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Jagsonpal is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Jagsonpal Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Jagsonpal Pharmaceuticals stock prices may prove useful in developing a viable investing in Jagsonpal Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 26.6 M | 28.8 M | |
Net Income Applicable To Common Shares | 307.3 M | 322.7 M |
Jagsonpal Pharmaceuticals Quarterly Net Working Capital |
|
Jagsonpal Pharmaceuticals Stock Technical Analysis
Jagsonpal Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
All Next | Launch Module |
Jagsonpal Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Jagsonpal Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Jagsonpal Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Jagsonpal to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1411 | |||
Jensen Alpha | 0.6461 | |||
Total Risk Alpha | 0.4622 | |||
Sortino Ratio | 0.2102 | |||
Treynor Ratio | 0.6822 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Jagsonpal Stock analysis
When running Jagsonpal Pharmaceuticals' price analysis, check to measure Jagsonpal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jagsonpal Pharmaceuticals is operating at the current time. Most of Jagsonpal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jagsonpal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jagsonpal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jagsonpal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |